Abstract: . . .  Page 36 30 Conjunctivitis 12. Wan WL, Farkas GC, May WN, Robin JB. The clinical characteristics and course of adult gonococcal conjunctivitis . Am J Ophthalmol 1986; 102:575-83. 13. Hierholzer JC, Wigand R, Anderson LJ, et al. Adenoviruses from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D (types 43-47). J Infect Dis 1988; 158:804-13. 14. Gordon JS. Adenoviral and other nonherpetic viral diseases. In: Smolin G, Thoft RA, eds. The cornea, 3rd ed. Boston: Little, Brown & Co, 1994:215-27. 15. Ford E, Nelson KE, Warren D. Epidemiology of epidemic keratoconjunctivitis. Epidemiol Rev 1987; 9:244-61. 16. Arrfa RC. Grayson's diseases of the cornea, 4th ed. St. Louis: Mosby-Year Book, 1997:286. 17. Smith IW, Peutherer JF, MacCallum FO. The incidence of Herpesvirus hominis antibody in the population. J Hyg (Lond) 1967; 65:395-408. 18. Burgoon CF, Burgoon JS, Baldridge GD. The natural history of herpes zoster. JAMA 1957; 164:265-7. 19. Karbassi M, Raizman MB, Schuman JS. Herpes zoster ophthalmicus. Surv Ophthalmol 1992; 36:395-410. 20. Washington AE, Johnson RE, Sanders LL Jr. Chlamydia trachomatis infections in the United States. What are they costing us? JAMA 1987; 257:2070-72. 21. Whitcher JP. Chlamydial keratitis and conjunctivitis . In: Smolin G, Thoft RA, eds. The cornea, 3rd ed. Boston: Little, Brown & Co, 1994:277-293. Page 37 References 31 22. Rothenberg R. Ophthalmia neonatorum due to Neisseria gonorrhoeae: prevention and treatment. Sex Transm Dis 1979; 6(2 suppl ):187-91. 23. Isenberg SJ, Apt L, Wood M. A controlled trial of povidone-iodine as prophylaxis against ophthalmia . . .
--3000,1,1500,2057,64741